BofA Merrill Upgrades Medicis (MRX) to Neutral, Downgrades Ironwood (IRWD) to Neutral, Cadence (CADX) to Underperform
Tweet Send to a Friend
An analyst at BofA Merrill Lynch revised investment ratings on a number of stocks in the Biotech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
